马斯克的"天价索赔"正处于人工智能军备竞赛升级阶段。 当地时间1月17日，马斯克在提交给美国联邦法院的文件中，向OpenAI和微软索要高达超过千亿美元的 赔偿金。 美国银行也在一份报告中指出，超大规模数据中心运营商的借贷规模今年将加速增长。他们预计，未来 三年，五大超大规模数据中心运营商的年均借贷额将达到约1400亿美元，甚至可能超过每年3000亿美 元。去年，共发行了1210亿美元的美国公司债券，而2020年至2024年间的年均发行量仅为280亿美元。 为了扩大收入，近日OpenAI还开始进行ChatGPT广告试点。分析师表示，广告收入有望从ChatGPT的8 亿周活跃用户中释放可观的收入来源，但此举可能会激怒部分用户，并损害用户对产品的信任。 马斯克表示，他在2015年联合创立OpenAI期间，为OpenAI提供了655亿美元至1094亿美元的资金，而微 软则获得了133亿美元至251亿美元的资金。这些资金总计可高达1300亿美元。 与此同时，OpenAI CEO奥尔特曼还在脑机接口领域与马斯克展开全方位的较量。就在近日，由奥尔特 曼联合创立的脑机接口公司Merge Labs宣布完成2.52亿美元融资，O ...

脑机接口是一项让大脑直接与外部设备建立通信通路的黑科技，既能帮助瘫痪患者重拾行动能力、视障患者恢复视觉感知，还在医疗、工业、交通等多个 领域逐步落地。 2025年，国家将脑机接口列入未来产业重点发展清单，政策支持密集加码，临床试验加速推进，资本市场持续火热。 （来源：东方财富） 元旦后首个交易日，资本市场便对该板块展开积极抢筹，板块指数当日大幅拉升13.24%，后续几日延续强势上涨态势，充分印证了资金持续流入的旺盛 动能。而近几日的缩量回调，更凸显出资金锁仓意愿强烈，筹码稳定性十足，进一步夯实了板块上涨的基础。 再者，全球巨头Neuralink即将启动设备规模化生产，国内企业也在技术研发上频频突破，脑机接口早已脱离实验室概念，成长为千亿级规模的黄金赛道， 新一轮投资机遇已然来临。 01 四重利好共振，脑机接口进入爆发前夜 脑机接口的崛起绝非偶然，政策、临床、融资、产业四大核心力量齐发力，推动行业迈入产业化关键阶段。 政策层面，国家从"中国脑计划"到"十五五"规划，持续将脑机接口列为重点发展方向，2025年更是密集出台支持政策，地方也纷纷设立专项资金，北京、 上海等城市还出台专项行动方案，为产业发展铺路。 临床 ...

Core Viewpoint - The research teams from Tsinghua University and Capital Medical University have developed a novel method to bypass the blood-brain barrier using nanoparticles to deliver drugs directly to stroke lesions, potentially overcoming a significant challenge in neurological disease treatment [1][3]. Group 1: Research Findings - The study reveals that the bone marrow within the skull is not a static structure but is connected to the meninges through microchannels, allowing immune cells to bypass the blood-brain barrier and enter the brain [3]. - The research team utilized a minimally invasive injection method to deliver albumin nanoparticles into the skull bone marrow, which were efficiently taken up by immune cells, forming "skull immune cell micro-nanobots" for targeted drug delivery [3][4]. - The nanoparticles demonstrated low systemic exposure, with minimal entry into peripheral blood and major organs, ensuring good biocompatibility and safety [3][4]. Group 2: Clinical Implications - In mouse models of acute ischemic stroke, the new delivery method significantly reduced infarct volume and edema, improved neurological function, and showed long-term benefits in reducing brain atrophy and enhancing survival rates [4]. - An exploratory clinical study involving 20 patients with malignant cerebral artery occlusion indicated that the procedure was well-tolerated, with no severe adverse events reported, and showed positive trends in neurological recovery [4][5]. Group 3: Future Prospects - The research suggests that this delivery pathway could extend beyond drug delivery, potentially integrating with brain-machine interface technologies to facilitate multi-directional exchanges of materials, energy, and information between the brain and artificial systems [5].

Group 1 - The core trend of the 21st century is that "the internet has become real life," impacting various aspects from communication to digital finance and health tracking [2][5][10] - The digital transformation is expected to permeate government processes, public health monitoring, and even brain-computer interfaces in the next two decades, with significant implications for power dynamics both within and between nations [2][11] - The civilizations that benefit the most from new technology waves are those that produce technology rather than merely consume it, emphasizing the need for equitable access to technology [3][12] Group 2 - The COVID-19 pandemic highlighted the consequences of unequal access to technology, particularly in vaccine production, where wealthier nations received vaccines earlier than poorer ones [5][8] - Transparency issues in vaccine science and distribution strategies have led to increased public distrust, which can undermine the effectiveness of health initiatives [8][12] - Solutions like open-source vaccine development can reduce inequality in access and enhance the ability to analyze and verify safety and efficacy [8][12] Group 3 - The importance of openness and verifiability in health and biotechnology is underscored, as proprietary systems can lead to monopolistic practices and data security risks [12][18] - The need for real-time data collection and communication in health monitoring is emphasized, which can significantly improve responses to public health threats [11][12] - The potential risks associated with proprietary health data systems include exploitation by hackers and the monopolization of critical health information by a few large companies [12][18] Group 4 - The article discusses the necessity of open-source and verifiable technologies across various sectors, including personal health tracking, governance, and public safety [23][24] - The vision for a future with open and verifiable systems includes secure personal devices, encrypted communications, and transparent governance mechanisms [23][24] - The call for a shift towards open-source technologies is framed as essential for ensuring security, freedom, and equitable access in the digital age [28][30]

Investment Rating - The industry rating is "Outperform the Market," indicating that the overall return of the industry is expected to exceed the market benchmark index by more than 5% in the next 6 months [6][13]. Core Insights - Merge Labs has successfully completed a seed round financing of approximately $250 million, achieving a valuation of $850 million. This financing was led by OpenAI, with its CEO Sam Altman participating as a co-founder and investor. Unlike mainstream brain-machine interface technologies, Merge Labs focuses on a non-invasive or minimally invasive approach centered on ultrasound, bypassing the traditional "electrode-neuron" paradigm [3][4]. - The brain-machine interface market is projected to grow rapidly, with the global market size expected to reach approximately $2.62 billion in 2024 and $2.94 billion in 2025, potentially growing to $12.4 billion by 2034, reflecting a compound annual growth rate (CAGR) of 17.35% over the next decade. In China, the market size is anticipated to be 3.2 billion yuan in 2024, increasing to 6.14 billion yuan by 2028 [5]. Summary by Sections Investment Highlights - Merge Labs' ultrasound-based technology aims to balance between non-invasive (safe but limited resolution) and invasive (clear signals but with surgical risks and ethical concerns) methods. The unique potential of ultrasound's deep penetration and "soft interface" concept is highlighted, although the technology is still in the laboratory research phase and faces multiple unresolved challenges [4]. Market Outlook - The report emphasizes the strategic importance of brain-machine interfaces as a key sector in the "14th Five-Year Plan," aiming to drive new economic growth points. The industry is expected to gain momentum over the next decade, potentially creating a new high-tech industry in China [5]. Recommended Companies - The report suggests monitoring companies such as Rock Mountain Technology, Hanwei Technology, Sanbo Brain Science, Innovation Medical, Dongfang Zhongke, Xiangyu Medical, Entropy Technology, Chengyitong, Weisi Medical, Meilan De, Aipeng Medical, and Beiyikang for potential investment opportunities [5].

Core Viewpoint - The ambitious goal of achieving a market value of 100 trillion USD in 20 years is presented as a feasible target based on historical trends of tech giants like Microsoft, Apple, and Nvidia, which have seen significant increases in their valuations over time [2][17]. Group 1: Strategic Recommendations - The company should leverage its core technology of "high-speed digital motors + AI algorithms" to expand into various sectors beyond home appliances, including automotive and aerospace [3][5]. - It is advised to adopt strategies from industry leaders: Nvidia's hardware and ecosystem integration, Apple's seamless user experience, and Microsoft's open platform approach to create a robust business model [5][6]. - The company should focus on global expansion and localization, establishing direct retail experiences in key markets to enhance brand presence and adapt products to local needs [6]. Group 2: Roadmap to Growth - The first phase (2026-2030) aims to solidify the company's foundation with a target market value of 50 billion USD, emphasizing R&D investment and market leadership in existing product categories [7][8]. - The second phase (2031-2035) focuses on expanding the ecosystem, targeting a market value of 500 billion USD, with plans to enter the automotive sector and develop partnerships for technology sharing [10]. - The third phase (2036-2040) aims for a market value of 3 trillion USD, with the goal of establishing industry standards and leading in smart living and robotics [11]. - The final phase (2041-2046) envisions a market value of 100 trillion USD, emphasizing groundbreaking technologies and a shift towards subscription services and data monetization [12][13]. Group 3: Financial Strategy - The company needs to secure diverse funding sources, including self-funding, equity financing, and strategic investments, to support its ambitious growth plans without relying solely on public offerings [16].

南京特殊教育师范学院党委副书记、校长王立新表示，近年来，学校紧跟时代步伐，布局脑机接口等前沿领域。未来，学校将充分发挥特教专业优势，与 各方携手攻克技术转化难题，让脑机接口技术更好地服务特殊群体，助力特殊教育迈向智能化、精准化新阶段。 当天，"特殊教育脑机接口联合创新中心"揭牌。江苏脑机接口研究院、南京特殊教育师范学院脑机科技研究院、南京仙林科技成果转化中心三方代表登台 签署共建协议。峰会正式成立"脑机接口高校创新联盟"，南京大学、南京师范大学、南京中医药大学、南京特殊教育师范学院等10所高校及相关机构成为 首批联盟单位。 1月17日，由江苏省残疾人联合会、栖霞区人民政府、南京市残疾人联合会、江苏省人民医院与南京特殊教育师范学院共同主办的"脑机智惠特教未来—— 产学研政企金协同峰会"在南京仙林科技成果转化中心举办。来自政府、产业、高校、科研、医疗、金融等领域的百余名代表齐聚一堂，共同探索脑机接 口前沿科技赋能特殊教育、服务残疾人群体的创新路径与实践方案。 江苏省残疾人联合会党组成员、副理事长廖章波指出，江苏脑机接口研究院、南京特殊教育师范学院及各合作企业携手成立"特殊教育脑机接口联合创新 中心"，是推动康教融 ...

脑机接口是国家"十五五"规划建议提出的六大未来产业之一。广州在脑机接口的科研、产业、生态方 面，均具备一定的发展根基。广州市政协委员、广东法丞汇俊律师事务所高级合伙人胡桂芬建议，广州 应系统性施策补齐短板，推动产业从基础积累向规模突破跨越，可分别在海珠区和黄埔区打造非侵入和 侵入式的产业集聚区。 广州市政协委员、广东法丞汇俊律师事务所高级合伙人胡桂芬。 胡桂芬在今年广州市两会上拟提交的提案，对广州市的脑机接口产业进行了系统梳理。 在科研端，琶洲实验室牵头承担国家科技创新2030"脑科学与类脑研究"重大项目，获近1.2亿元经费支 持，其非侵入式脑机接口共性技术平台获批国家重点项目。 在产业端，广州已经孵化出华南脑控、宁脑智能、析芒医疗等优质企业，非侵入式和侵入式技术均有布 局。 在生态端，粤港澳大湾区脑机接口创新产业联盟（筹）启动，珠江医院设立华南首个脑机接口临床研究 病房，结合雄厚医疗资源与大湾区协同优势，构建起"科研—临床—产业"初步体系。 在现有发展基础上，胡桂芬指出，广州的脑机接口产业面临两大核心瓶颈，制约其高质量进阶，分别 是：缺乏专项政策、中期投资断层。 在政策层面，胡桂芬在提案中指出，广州对脑机接 ...

Group 1 - The China Securities Regulatory Commission (CSRC) emphasizes maintaining market stability and preventing excessive speculation and manipulation, aiming to consolidate the positive momentum in the market [1] - The A-share market has seen a surge in margin trading balances, indicating increased trading activity, while popular concepts like commercial aerospace and AI applications have driven a strong market opening [1] - Regulatory measures include raising the financing margin ratio to 100% and halting trading of stocks with excessive short-term gains, reflecting a strategy to cool down the overheated market [1] Group 2 - Popular concepts such as commercial aerospace and AI applications represent future industry directions, reflecting market confidence in technological development [2] - Some companies are criticized for lacking substantial technological foundations and merely riding the wave of popular trends without core patents or product development [2] - The regulatory stance aims to differentiate between genuine innovation and companies that lack fundamental support, encouraging firms to focus on improving operational quality and transparency for sustainable growth [2]

Core Viewpoint - The market is experiencing a "good start" in 2026, with unexpected activity in the stock and commodity markets, driven by three main factors: industrial momentum, funding dynamics, and emotional factors [1][2]. Group 1: Market Drivers - **Industrial Momentum**: Advances in cutting-edge technology sectors such as AI, biopharmaceuticals, and brain-computer interfaces are highlighted as key attractions in the capital market, supported by the "14th Five-Year Plan" [1]. - **Funding Dynamics**: Reforms in the capital market since September 2024 and encouragement for long-term capital investment have led domestic investors to gradually increase their allocation to equity assets [1]. - **Emotional Factors**: Geopolitical issues have shifted global demand from dollar assets to other assets, resulting in a moderate inflow of foreign capital into the Chinese market [1]. Group 2: Economic Balance - The performance of the market must remain balanced with economic fundamentals, as there are still areas needing improvement, such as domestic demand, consumption, and real estate [1]. - To bridge the gap between market performance and economic fundamentals, stabilizing the real estate sector through measures like lowering or subsidizing mortgage rates is essential [1]. - Supporting consumption and accelerating social security system reforms are also critical to unlocking residents' consumption potential [1].